CIK 0000948320 · Accelerated filer
LifeMD, Inc.
Sign in to watch- Ticker
- LFMD
- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 760238453
- Phone
- (866) 351-5907
- Business address
- 236 FIFTH AVENUE, SUITE 400, NEW YORK, NY, 10001
- Former names
- CONVERSION LABS, INC., Immudyne, Inc.
Securities
- LFMD Common Stock Nasdaq
- LFMDP 8.875% Series A Cumulative Perpetual Preferred Stock Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 86 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-11 | Benathen Marc David Chief Financial Officer | Returned to the company · Employee Stock Option (Right to Buy) | −200,000 | 0 | ||
| 2023-07-11 | Benathen Marc David Chief Financial Officer | Option exercise · Restricted Stock | −25,000 | 0 | ||
| 2023-06-20 | FEBBO WILLIAM J Director | Grant or award | +75,000 | 450,000 | ||
| 2023-06-20 | FEBBO WILLIAM J Director | Grant or award · Employee Stock Option (Right to Buy) | +37,500 | 37,500 | ||
| 2023-06-15 | Yecies Eric Harold General Counsel & CCO | Grant or award | +150,000 | 212,500 | ||
| 2023-06-15 | Yecies Eric Harold General Counsel & CCO | Returned to the company · Employee Stock Option (Right to Buy) | −200,000 | 0 | ||
| 2023-06-14 | BHATIA NAVEEN Director | Grant or award | +225,000 | 487,349 | ||
| 2023-06-14 | Jindal Piyush Director | Grant or award | +225,000 | 300,000 | ||
| 2023-06-14 | Velge Bertrand Director | Purchase | +3,945 | $2.94 | $12K | 212,310 |
| 2023-06-14 | Alvarez Nicholas P Chief Acquisition Officer | Purchase | +10,712 | $2.92 | $31K | 180,000 |
| 2023-06-13 | Velge Bertrand Director | Purchase | +49,465 | $2.64 | $130K | 213,465 |
| 2023-06-13 | Roberts Brad Michael COO | Grant or award | +150,000 | 247,632 | ||
| 2023-06-13 | Roberts Brad Michael COO | Returned to the company · Employee Stock Option (Right to Buy) | −200,000 | 0 | ||
| 2023-06-13 | Velge Bertrand Director | Purchase | +44,365 | $2.64 | $117K | 208,365 |
| 2023-06-13 | Yecies Eric Harold General Counsel & CCO | Purchase | +11,500 | $2.60 | $30K | 62,500 |
| 2023-06-07 | Velge Bertrand Director | Purchase | +24,500 | $2.19 | $54K | 164,000 |
| 2023-06-07 | Velge Bertrand Director | Purchase | +24,500 | $2.19 | $54K | 164,000 |
| 2023-06-06 | Velge Bertrand Director | Purchase | +129,117 | $2.18 | $281K | 139,500 |
| 2023-06-05 | Velge Bertrand Director | Purchase | +10,383 | $2.17 | $22K | 10,383 |
| 2023-05-26 | Roberts Brad Michael Chief Operating Officer | Purchase | +30,000 | $2.19 | $66K | 97,632 |
Page 6 of 8 · 146 trades